Stage 1 diabetes
Showing 1 - 25 of >10,000
Type 1 Diabetes Trial (teplizumab)
Not yet recruiting
- Type 1 Diabetes
- teplizumab
- (no location specified)
Mar 6, 2023
Diabetes, Type 1 Trial in Cairo (oral omega-3 fatty acids supplementation, Placebo)
Completed
- Diabetes Mellitus, Type 1
- oral omega-3 fatty acids supplementation
- Placebo
-
Cairo, EgyptNancy Elbarbary
Aug 4, 2023
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Charlottesville (Continuous Glucose Monitor)
Completed
- Diabetes
- +2 more
- Continuous Glucose Monitor
-
Charlottesville, VirginiaMeaghan Stumpf, MD
Nov 29, 2022
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023
Diabetes, Type 1 Trial (Antithymocyte Globulin, Placebo (for ATG))
Recruiting
- Diabetes Mellitus, Type 1
- Antithymocyte Globulin
- Placebo (for ATG)
-
Gainesville, FloridaUniversity of Florida
Jan 5, 2023
Diabetes, Type 1 Trial in San Diego (Golimumab)
Available
- Diabetes Mellitus, Type 1
-
San Diego, CaliforniaRady Children's Hospital
Jul 28, 2022
Diabetes;Uremia Trial in Guangzhou (simultaneous pancreas-kidney transplantation)
Recruiting
- Diabetes Mellitus；Uremia
- simultaneous pancreas-kidney transplantation
-
Guangzhou, Guangdong, China1Department of Organ Transplantation, Second Affiliated Hospital
Aug 10, 2022
Early Stage Retinal Abnormalities in Type 1 Diabetes, Screened
Recruiting
- Type 1 Diabetes Patients
- Retinal imaging assessment
- blood glucose holter
-
Dijon, FranceCHU Dijon Bourgogne
Mar 9, 2022
Type 1 Diabetes, Prediabetic State, Dysglycemia Trial in Aurora (Early CGM-guided education and initiation of insulin therapy.,
Enrolling by invitation
- Type 1 Diabetes
- +3 more
- Early CGM-guided education and initiation of insulin therapy.
- Usual care: glucometer surveillance and basic education.
-
Aurora, ColoradoBarbara Davis Center
May 6, 2022
Kidney Alone Versus Islet-After-Kidney in Type 1 Diabetic Kidney
Recruiting
- type1diabetes
- +2 more
- Pancreatic islet transplantation after kidney transplantation
-
Lille, FranceHop Claude Huriez Chu Lille
Dec 21, 2022
Post-transplant Diabetes, New Onset Diabetes After Transplant, New Onset Diabetes After Transplantation Trial in London
Completed
- Post-transplant Diabetes Mellitus
- +6 more
- Metformin
- Placebo
-
London, United KingdomRoyal London Hospital, Barts Health NHS Trust
Oct 17, 2022
Type 1 Diabetes Trial in Milan (Medtronic MiniMed 780G with SmartGuard activation, Medtronic MiniMed 780G without SmartGuard
Recruiting
- Type 1 Diabetes
- Medtronic MiniMed 780G with SmartGuard activation
- Medtronic MiniMed 780G without SmartGuard activation
-
Milan, ItalyASST FBF Sacco
Jul 25, 2022
Loss-of-control Eating, Obesity/Overweight Trial in New Haven (drug, behavioral, other)
Recruiting
- Loss-of-control Eating
- Obesity/Overweight
- Naltrexone and Bupropion medication
- +2 more
-
New Haven, ConnecticutYale Department of Psychiatry
Oct 4, 2022
Stage 1 Diabetes, Type 1 Trial in München (Oral Insulin, Placebo)
Active, not recruiting
- Stage 1 Diabetes Mellitus, Type 1
- Oral Insulin
- Placebo
-
München, Deutschland (deu), GermanyForschergruppe Diabetes, Klinikum rechts der Isar, Technische Un
Jun 21, 2021
Type 2 Diabetes, Diabetes, Type 2, Renal Transplant Trial in London (AZD1656, Placebo)
Recruiting
- Type 2 Diabetes
- +4 more
- AZD1656
- Placebo
-
London, United KingdomRoyal London Hospital Barts Health NHS Trust
Feb 4, 2022
Type 1 Diabetes, Insulin-requiring Type 2 Diabetes, End Stage Renal Disease (ESRD) Trial (Artificial Pancreas, Multiple Daily
Withdrawn
- Type 1 Diabetes
- +2 more
- Artificial Pancreas
- Multiple Daily Injections
- (no location specified)
Nov 2, 2021
CKD, Diabetic Kidney Disease, Type 2 Diabetes in Obese Trial in Danville, Wilkes-Barre (Semaglutide 2 mg/1.5 ml (1.34 mg/ml),
Recruiting
- CKD
- +4 more
- Semaglutide 2 mg/1.5 ml (1.34 mg/ml), prefilled pen-injector for subcutaneous injection solution
- Placebo 1.5 ml, prefilled pen-injector for subcutaneous injection solution
-
Danville, Pennsylvania
- +1 more
Feb 3, 2022
Trial of KidneyIntelX
Recruiting
- Diabetic Kidney Disease
- +4 more
- KidneyIntelX
-
New York, New YorkMount Sinai Health System
Jan 5, 2022
Prospective Decision Impact Trial of KidneyIntelX
Recruiting
- Diabetic Kidney Disease
- +3 more
- KidneyIntelX
-
Winston-Salem, North CarolinaAtrium Health Wake Forest Baptist - Family Medicine - Piedmont P
Nov 22, 2021
Medication Adherence, Kidney Transplantation Trial in Canada, United States (Adherence Intervention, Healthy living education
Active, not recruiting
- Medication Adherence
- Kidney Transplantation
- Adherence Intervention
- Healthy living education intervention
-
Saint Louis, Missouri
- +7 more
Jan 27, 2023
End Stage Renal Disease, Hypertension, Diabete Type 2 Trial in Montreal (Medication reconciliation supplemented with MedSafer
Enrolling by invitation
- End Stage Renal Disease
- +5 more
- Medication reconciliation supplemented with MedSafer and deprescribing brochures
-
Montreal, Quebec, CanadaMcGill University Health Centre
Oct 15, 2022
Islet Autoantibodies Screening in Families of Type-1 Diabetes
Not yet recruiting
- Type 1 Diabetes
-
Petach-Tikva, IsraelSchneider Children Medical Center of Israel
Mar 15, 2023
Type 1 Diabetes Trial (Semaglutide weekly injection)
Not yet recruiting
- Type 1 Diabetes
- Semaglutide weekly injection
- (no location specified)
Sep 21, 2023
Diabetes 1 or 2, Midfoot Charcot Neuroarthropathy Trial in Rostock (Surgery with Midfoot Fusion Bolt, Cast treatment)
Terminated
- Diabetes Mellitus 1 or 2
- Midfoot Charcot Neuroarthropathy
- Surgery with Midfoot Fusion Bolt
- Cast treatment
-
Rostock, GermanyDept. of Trauma and Reconstructive Surgery, University of Rostoc
Jul 21, 2021